The company received a $100.00K grant investment on 18 May 2023 from the Advanced Industries Accelerator (AIA) Program. With a dedicated global clientele since the early 1990s, TopoGEN emphasizes substantial product support, data interpretation, and consultation advice, positioning themselves as research partners for their customers. As they continue to contribute to the advancement of cancer research, TopoGEN presents an attractive investment opportunity within the biotechnology and healthcare industries.
TopoGEN, Inc.
Products and Services for Cancer Research
Founded 1991
6 employees
Grant
Total: $100.00K
Biotechnology, Health Care
General Information
Company Name
TopoGEN, Inc.
Founded Year
1991
Employees
6
Industries
Biotechnology, Health Care
Funding Stage
Grant
BounceWatch is an independent company data service, not affiliated with TopoGEN, Inc.. To contact TopoGEN, Inc., visit topogen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About TopoGEN, Inc.
Taxonomy: Cancer Research, Drug Discovery, Topoisomerases, Diagnostic Products, Assay Kits, DNA Substrates, Cell based screening, Mechanism-based Drug Development, Anticancer Agents, Molecular Genetics, Research Services, Data Interpretation, Consultation, Contract Screening
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $100.00K | 1 |
Advanced Industries Accelerator (AIA) Program
|
18 May 2023 |
TopoGEN, Inc. Alternatives & Competitors
View All Alternatives
TopoGEN, Inc. vs
Cepham Life Sciences, Inc.
United States
Develop and manufacture wide range of products in the areas of Proteomics, Molecular Biology & Drug...
4 employees
Biotechnology, Health Care
TopoGEN, Inc. vs
StemoniX
United States
Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research
Convertible Note
1 employees
Biotechnology, Health Care
TopoGEN, Inc. vs
Pioneering cell-based diagnostic solutions to empower physicians with timely and accurate cancer ins...
Series F
Biotechnology, Health Care
FAQ About TopoGEN, Inc.
Products and Services for Cancer Research
TopoGEN, Inc. was founded in 1991.
TopoGEN, Inc. operates in Biotechnology and Health Care. Its work centres on Cancer Research, Drug Discovery, Topoisomerases and Diagnostic Products.
TopoGEN, Inc. has approximately 6 employees.
TopoGEN, Inc. has completed 1 funding round, raising a total of $100.00K. The latest funding stage is Grant.
Top alternatives and competitors to TopoGEN, Inc. include Cepham Life Sciences, Inc., StemoniX, Immunicon, Singlera Genomics Incorporated, BioTrove. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TopoGEN, Inc. and Cepham Life Sciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for TopoGEN, Inc., https://bouncewatch.com/company/topogen-inc, updated 24 December 2024. When citing, please name BounceWatch and link this page.
